銀抗菌ドレッシング市場 - 世界および地域の分析：地域・国別分析・競合情勢・分析と予測 (2023～2030年)

世界の銀抗菌ドレッシングの市場規模は、2022年の9億8,540万米ドルから、2023年から2030年にかけての予測期間中はCAGR 3.11％で堅調に推移し、2030年には12億5630万米ドルに達すると予測されています。

このような成長の背景には、効果的な保護を与え、治癒を促進し、患者の快適性を高める高度な創傷ケアソリューションに対する需要の増加があります。

世界の銀抗菌ドレッシング市場は、銀の抗菌特性を活用するために銀を組み込んだ創傷ケア製品に焦点を当てていることが特徴です。これらのドレッシング材は、手術創、火傷、潰瘍、その他感染予防が重要な慢性・急性創傷を含む様々な創傷の治療に使用されます。この市場は主に、糖尿病性潰瘍、褥瘡、静脈性下腿潰瘍などの慢性創傷の有病率の増加と、世界の外科手術件数の増加、創傷治療技術の進歩によって牽引されています。さらに、効果的な創傷管理の重要性に対する意識の高まりと世界のヘルスケア支出の増加が、銀系抗菌ドレッシング材市場の成長をさらに促進しています。しかし、先進的なドレッシング材のコストが高いこと、新しいタイプの銀ドレッシング材の有効性を裏付ける臨床的証拠が必要であることは、この市場が直面する課題です。

地域別で見ると、市場規模では欧州がリードしており、2022年の3億610万米ドルから、予測期間中はCAGR 2.21%で推移し、2030年には3億6,430万米ドルの規模に達すると予測されています。これは同地域の強固な医療システムと質の高い創傷ケアへの注力、革新的な創傷ケアソリューションの高い採用率を反映しています。一方、その他の地域はCAGR 4.67%でもっとも高い成長率を示す見通しであり、これは医療の急速な進歩や高度な創傷管理に対する意識の高まりに起因しています。ラテンアメリカとアジア太平洋地域も、医療インフラの改善と最新医療技術へのアクセス拡大により、それぞれCAGR 4.27%、4.00%の成長が見込まれています。

参入企業：

• 3M
• Smith & Nephew
• Convatec Inc.
• Molnlycke Health Care AB
• B. Braun
• Cardinal Health
• Coloplast
• L&R Group
• DermaRite Industries, LLC.
• Gentell
• Winner Medical Co., Ltd.
• McKesson Corporation

当レポートでは、世界の銀抗菌ドレッシングの市場を調査し、市場概要、市場規模の推移・予測、地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

第1章 市場

第2章 地域

• 地域別概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • オーストリア
  • チェコ共和国
  • ギリシャ
  • ポーランド
  • ルーマニア
  • ロシア
  • スロバキア
  • トルコ
  • ウクライナ
  • ベルギー
  • デンマーク
  • フィンランド
  • フランス
  • アイルランド
  • イタリア
  • オランダ
  • ノルウェー
  • ポルトガル
  • スペイン
  • スウェーデン
  • スイス
  • 英国
• アジア太平洋
  • オーストラリア
  • 中国
  • インド
  • 日本
  • マレーシア
  • 韓国
  • タイ
• ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • チリ
  • コロンビア
  • メキシコ
• その他の地域

第3章 市場：競合ベンチマーキング

• 主な戦略・展開
• 主要企業エコシステム

第4章 調査手法

List of Figures

• Figure 1: Global Silver Antimicrobial Dressings Market, $Million, 2022, 2026, and 2030
• Figure 2: Global Silver Antimicrobial Dressings Market (by Region), $Million, 2022, 2026, and 2030
• Figure 3: Key Market Trends in Global Silver Antimicrobial Dressings Market, 2023
• Figure 4: U.S. Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 5: Canada Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 6: Germany Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 7: Austria Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 8: Czech Republic Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 9: Greece Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 10: Poland Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 11: Romania Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 12: Russian Federation Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 13: Slovakia Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 14: Turkey Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 15: Ukraine Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 16: Belgium Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 17: Denmark Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 18: Finland Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 19: France Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 20: Ireland Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 21: Italy Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 22: Netherlands Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 23: Norway Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 24: Portugal Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 25: Spain Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 26: Sweden Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 27: Switzerland Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 28: U.K. Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 29: Australia Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 30: China Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 31: India Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 32: Japan Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 33: Malaysia Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 34: South Korea Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 35: Thailand Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 36: Argentina Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 37: Brazil Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 38: Chile Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 39: Colombia Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 40: Mexico Silver Antimicrobial Dressings Market, $Million, 2021-2030
• Figure 41: Data Triangulation
• Figure 42: Top-Down and Bottom-Up Approach
• Figure 43: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Global Silver Antimicrobial Dressings Market, Opportunities
• Table 3: Global Silver Antimicrobial Dressings Market (by Region), $Million, 2021-2030
• Table 4: North America Silver Antimicrobial Dressings Market (by Country), $Million, 2021-2030
• Table 5: Europe Silver Antimicrobial Dressings Market (by Country), $Million, 2021-2030
• Table 6: Asia-Pacific Silver Antimicrobial Dressings Market (by Country), $Million, 2021-2030
• Table 7: Latin America Silver Antimicrobial Dressings Market (by Country), $Million, 2021-2030
• Table 8: Rest-of-the-World Silver Antimicrobial Dressings Market (by Country), $Million, 2021-2030
• Table 9: Key Initiatives, 2020-2024
• Table 10: Key Companies, Global Silver Antimicrobial Dressing Market

Global Silver Antimicrobial Dressings Market Industry Overview

The global silver antimicrobial dressings market, valued at $985.4 million in 2022, is on a trajectory of robust growth and is anticipated to reach $1,256.3 million by 2030. This market is expected to expand at a compound annual growth rate (CAGR) of 3.11% between 2023 and 2030. Such growth is fueled by an increasing demand for advanced wound care solutions that offer effective protection, promote healing, and enhance patient comfort.

Market Introduction

The global silver antimicrobial dressings market has been characterized by its focus on wound care products that incorporate silver to leverage its antimicrobial properties. These dressings are used in treating a variety of wounds, including surgical wounds, burns, ulcers, and other types of chronic and acute wounds, where infection prevention is crucial. The market is primarily driven by the increasing prevalence of chronic wounds such as diabetic ulcers, pressure ulcers, and venous leg ulcers, coupled with a rising number of surgical procedures globally and advancements in wound care technologies. Additionally, the rise in awareness about the importance of effective wound management, coupled with increasing healthcare expenditure globally, is further propelling the growth of the silver antimicrobial dressings market. However, the high cost of advanced dressings and the need for clinical evidence to support the efficacy of newer types of silver dressings are some challenges faced by this market.

Regional Segmentation:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Russian Federation
  • Turkey
  • Poland
  • Belgium
  • Sweden
  • Ireland
  • Norway
  • Austria
  • Denmark
  • Finland
  • Portugal
  • Czech Republic
  • Romania
  • Greece
  • Slovakia
  • Ukraine
• Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Malaysia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Colombia
  • Argentina
  • Chile
• Rest-of-the-World

The global silver antimicrobial dressings market has been witnessing varied growth rates across different regions, with a total market valuation rising from $985.4 million in 2022 to an anticipated $1,256.3 million by 2030, achieving a CAGR of 3.11%. Europe leads in terms of market size, growing from $306.1 million in 2022 to a projected $364.3 million by 2030 at a CAGR of 2.21%, reflecting the region's strong healthcare systems and focus on quality wound care and high adoption rates of innovative wound care solutions. Rest-of-the-World, however, is expected to showcase the highest growth rate at a 4.67% CAGR, attributed to rapid healthcare advancements and increasing awareness of advanced wound management. Europe is expected to present a steady growth due to established healthcare systems and a focus on quality wound care at a 2.21% CAGR, which is underpinned by its advanced healthcare infrastructure, focus on quality wound care and high adoption rates of innovative wound care solutions. Latin America and Asia-Pacific regions are not far behind and are expected to grow at CAGRs of 4.27% and 4.00%, respectively, driven by improvements in healthcare infrastructure and expanding access to modern medical technologies. This regional analysis underscores the global demand for silver antimicrobial dressings, fueled by a growing need for effective wound care across diverse healthcare landscapes.

How can this report add value to an organization?

Product/Innovation Strategy: Manufacturers leverage advancements in materials science, nanotechnology, and biotechnology to develop silver dressings with enhanced properties. Integration of technologies such as sustained-release mechanisms, nanofibers, and advanced wound matrices allows for more effective antimicrobial action and better wound healing outcomes.

Growth/Marketing Strategy: The report aids in identifying high-growth regions, enabling companies to allocate resources efficiently and prioritize market entry or expansion efforts where the potential return on investment is highest.

Competitive Strategy: Regional analysis provides a clear view of who the local competitors are, their market share, and their strengths and weaknesses. This knowledge allows companies to benchmark their offerings and strategize on how to differentiate themselves.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• The base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2019-FY2021. The market size has been estimated for FY2022 and projected for the period FY2023-FY2030.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of upstream and downstream products of silver antimicrobial dressings.
• The market contribution of silver antimicrobial dressings anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
• Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
• The market has been mapped based on the available silver antimicrobial dressing solutions. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in silver antimicrobial dressings, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report's segmentation and key qualitative findings
• Understanding the competitive landscape and business model
• Current and proposed production values of a product by market players
• Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their product portfolio
• Gold standard magazines, journals, white papers, press releases, and news articles
• Paid databases

The key data points taken from the secondary sources include:

• Segmentations and percentage shares
• Data for market value
• Key industry trends of the top players of the market
• Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The competitive landscape of the global silver antimicrobial dressings market has been shaped by several key players, each bringing a rich history of innovation and a broad portfolio of products tailored to meet the diverse needs of wound care. Among these, Smith & Nephew, 3M, Coloplast Corp., Medline Industries, Molnlycke, and McKesson Medical Surgical Inc. stand out due to their significant contributions, extensive product offerings, and global reach. The competitive dynamics among these companies are characterized by a continuous drive for product innovation, strategic global expansion, and the development of products that address the evolving challenges of wound care. Each company brings its unique strengths to the market, from Smith & Nephew's long-standing history and innovation, 3M's broad product range and technological leadership, to Coloplast's rapid growth and focus on healthcare solutions. Together, they contribute to a highly competitive and dynamic global silver antimicrobial dressings market aimed at improving patient outcomes and advancing the field of wound care.

Some of the prominent companies in this market are:

• 3M
• Smith & Nephew
• Convatec Inc.
• Molnlycke Health Care AB
• B. Braun
• Cardinal Health
• Coloplast
• L&R Group
• DermaRite Industries, LLC.
• Gentell
• Winner Medical Co., Ltd.
• McKesson Corporation

Table of Contents

Executive Summary

1 Markets

• 1.1 Product Definition
• 1.2 Inclusion and Exclusion Criteria
  • 1.2.1 Inclusion
  • 1.2.2 Exclusion Criteria
• 1.3 Key Questions Answered
• 1.4 Analysis and Forecast Note
• 1.5 Key Findings

2 Regions

• 2.1 Regional Summary
• 2.2 North America
  • 2.2.1 U.S.
  • 2.2.2 Canada
• 2.3 Europe
  • 2.3.1 Germany
  • 2.3.2 Austria
  • 2.3.3 Czech Republic
  • 2.3.4 Greece
  • 2.3.5 Poland
  • 2.3.6 Romania
  • 2.3.7 Russian Federation
  • 2.3.8 Slovakia
  • 2.3.9 Turkey
  • 2.3.10 Ukraine
  • 2.3.11 Belgium
  • 2.3.12 Denmark
  • 2.3.13 Finland
  • 2.3.14 France
  • 2.3.15 Ireland
  • 2.3.16 Italy
  • 2.3.17 Netherlands
  • 2.3.18 Norway
  • 2.3.19 Portugal
  • 2.3.20 Spain
  • 2.3.21 Sweden
  • 2.3.22 Switzerland
  • 2.3.23 U.K.
• 2.4 Asia-Pacific
  • 2.4.1 Australia
  • 2.4.2 China
  • 2.4.3 India
  • 2.4.4 Japan
  • 2.4.5 Malaysia
  • 2.4.6 South Korea
  • 2.4.7 Thailand
• 2.5 Latin America
  • 2.5.1 Argentina
  • 2.5.2 Brazil
  • 2.5.3 Chile
  • 2.5.4 Colombia
  • 2.5.5 Mexico
• 2.6 Rest-of-the-World

3 Markets - Competitive Benchmarking

• 3.1 Key Strategies and Developments
• 3.2 Key Companies Ecosystem

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast